BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 26115422)

  • 1. PAX5 alterations in genetically unclassified childhood Precursor B-cell acute lymphoblastic leukaemia.
    Stasevich I; Inglott S; Austin N; Chatters S; Chalker J; Addy D; Dryden C; Ancliff P; Ford A; Williams O; Kempski H
    Br J Haematol; 2015 Oct; 171(2):263-272. PubMed ID: 26115422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Genomic Landscape of PAX5, IKZF1, and CDKN2A/B Alterations in B-Cell Precursor Acute Lymphoblastic Leukemia.
    Ou Z; Sherer M; Casey J; Bakos HA; Vitullo K; Hu J; Friehling E; Gollin SM; Surti U; Yatsenko SA
    Cytogenet Genome Res; 2016; 150(3-4):242-252. PubMed ID: 28214896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAX5 mutations occur frequently in adult B-cell progenitor acute lymphoblastic leukemia and PAX5 haploinsufficiency is associated with BCR-ABL1 and TCF3-PBX1 fusion genes: a GRAALL study.
    Familiades J; Bousquet M; Lafage-Pochitaloff M; Béné MC; Beldjord K; De Vos J; Dastugue N; Coyaud E; Struski S; Quelen C; Prade-Houdellier N; Dobbelstein S; Cayuela JM; Soulier J; Grardel N; Preudhomme C; Cavé H; Blanchet O; Lhéritier V; Delannoy A; Chalandon Y; Ifrah N; Pigneux A; Brousset P; Macintyre EA; Huguet F; Dombret H; Broccardo C; Delabesse E
    Leukemia; 2009 Nov; 23(11):1989-98. PubMed ID: 19587702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and production of aberrant PAX5 with deletion of exon 8 in B-lineage acute lymphoblastic leukaemia of children.
    Sadakane Y; Zaitsu M; Nishi M; Sugita K; Mizutani S; Matsuzaki A; Sueoka E; Hamasaki Y; Ishii E
    Br J Haematol; 2007 Jan; 136(2):297-300. PubMed ID: 17129225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia.
    Shah S; Schrader KA; Waanders E; Timms AE; Vijai J; Miething C; Wechsler J; Yang J; Hayes J; Klein RJ; Zhang J; Wei L; Wu G; Rusch M; Nagahawatte P; Ma J; Chen SC; Song G; Cheng J; Meyers P; Bhojwani D; Jhanwar S; Maslak P; Fleisher M; Littman J; Offit L; Rau-Murthy R; Fleischut MH; Corines M; Murali R; Gao X; Manschreck C; Kitzing T; Murty VV; Raimondi S; Kuiper RP; Simons A; Schiffman JD; Onel K; Plon SE; Wheeler D; Ritter D; Ziegler DS; Tucker K; Sutton R; Chenevix-Trench G; Li J; Huntsman DG; Hansford S; Senz J; Walsh T; Lee M; Hahn CN; Roberts K; King MC; Lo SM; Levine RL; Viale A; Socci ND; Nathanson KL; Scott HS; Daly M; Lipkin SM; Lowe SW; Downing JR; Altshuler D; Sandlund JT; Horwitz MS; Mullighan CG; Offit K
    Nat Genet; 2013 Oct; 45(10):1226-1231. PubMed ID: 24013638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of PML as novel PAX5 fusion partner in childhood acute lymphoblastic leukaemia.
    Nebral K; König M; Harder L; Siebert R; Haas OA; Strehl S
    Br J Haematol; 2007 Oct; 139(2):269-74. PubMed ID: 17897302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The correlation between Pax5 deletion and patients survival in Iranian children with precursor B-cell acute lymphocytic leukemia.
    Moafi A; Zojaji A; Salehi R; Najafi Dorcheh S; Rahgozar S
    Cell Mol Biol (Noisy-le-grand); 2017 Aug; 63(8):19-22. PubMed ID: 28886309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of PAX5 gene in the early stages of leukemic B cells in the childhood B cell acute lymphoblastic leukemia.
    Firtina S; Sayitoglu M; Hatirnaz O; Erbilgin Y; Oztunc C; Cinar S; Yildiz I; Celkan T; Anak S; Unuvar A; Devecioglu O; Timur C; Aydogan G; Akcay A; Atay D; Turkkan E; Karaman S; Orhaner B; Sarper N; Deniz G; Ozbek U
    Leuk Res; 2012 Jan; 36(1):87-92. PubMed ID: 21813177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAX5-KIAA1549L: a novel fusion gene in a case of pediatric B-cell precursor acute lymphoblastic leukemia.
    Anderl S; König M; Attarbaschi A; Strehl S
    Mol Cytogenet; 2015; 8():48. PubMed ID: 26157485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One missense mutation in exon 2 of the PAX5 gene in Iran.
    Yazdanparast S; Khatami SR; Galehdari H; Jaseb K
    Genet Mol Res; 2015 Dec; 14(4):17768-75. PubMed ID: 26782422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAX5 deletion is common and concurrently occurs with CDKN2A deletion in B-lineage acute lymphoblastic leukemia.
    Kim M; Choi JE; She CJ; Hwang SM; Shin HY; Ahn HS; Yoon SS; Kim BK; Park MH; Lee DS
    Blood Cells Mol Dis; 2011 Jun; 47(1):62-6. PubMed ID: 21549623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and diversity of PAX5 fusion genes in childhood acute lymphoblastic leukemia.
    Nebral K; Denk D; Attarbaschi A; König M; Mann G; Haas OA; Strehl S
    Leukemia; 2009 Jan; 23(1):134-43. PubMed ID: 19020546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mutation and expression of PAX5 gene in adult acute lymphoblastic leukemia].
    Lin ZK; Zhang R; Ge Z; Xu JY; Liu J; Guo X; Li M; Wu YJ; Qiao C; Qiu HR; Zhang JF; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1206-11. PubMed ID: 25338558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Deletions and rearrangements of PAX5 gene in B-lineage acute lymphoblastic leukemia].
    Zheng JF; Dong SS; Wang Q; Pan JL; Chen SN; Qiu HY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Oct; 30(5):549-52. PubMed ID: 24078568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAX5/TEL acts as a transcriptional repressor causing down-modulation of CD19, enhances migration to CXCL12, and confers survival advantage in pre-BI cells.
    Fazio G; Palmi C; Rolink A; Biondi A; Cazzaniga G
    Cancer Res; 2008 Jan; 68(1):181-9. PubMed ID: 18172310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ph-like acute lymphoblastic leukemia with a novel PAX5-KIDINS220 fusion transcript.
    Sakamoto K; Imamura T; Kanayama T; Yano M; Asai D; Deguchi T; Hashii Y; Tanizawa A; Ohshima Y; Kiyokawa N; Horibe K; Sato A
    Genes Chromosomes Cancer; 2017 Apr; 56(4):278-284. PubMed ID: 27870151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia.
    Mullighan CG; Goorha S; Radtke I; Miller CB; Coustan-Smith E; Dalton JD; Girtman K; Mathew S; Ma J; Pounds SB; Su X; Pui CH; Relling MV; Evans WE; Shurtleff SA; Downing JR
    Nature; 2007 Apr; 446(7137):758-64. PubMed ID: 17344859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional heterogeneity of PAX5 chimeras reveals insight for leukemia development.
    Fortschegger K; Anderl S; Denk D; Strehl S
    Mol Cancer Res; 2014 Apr; 12(4):595-606. PubMed ID: 24435167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable breakpoints target PAX5 in patients with dicentric chromosomes: a model for the basis of unbalanced translocations in cancer.
    An Q; Wright SL; Konn ZJ; Matheson E; Minto L; Moorman AV; Parker H; Griffiths M; Ross FM; Davies T; Hall AG; Harrison CJ; Irving JA; Strefford JC
    Proc Natl Acad Sci U S A; 2008 Nov; 105(44):17050-4. PubMed ID: 18957548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGH@ translocations, CRLF2 deregulation, and microdeletions in adolescents and adults with acute lymphoblastic leukemia.
    Moorman AV; Schwab C; Ensor HM; Russell LJ; Morrison H; Jones L; Masic D; Patel B; Rowe JM; Tallman M; Goldstone AH; Fielding AK; Harrison CJ
    J Clin Oncol; 2012 Sep; 30(25):3100-8. PubMed ID: 22851563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.